Dr. Tosco Urology: what changed
Dr. Tosco Urology
Largest movements
- Cash +€42,488
new in 2025: €42,488
mainly Net result for the year (+€21,810) and Tax, wage and social debts (+€11,344)
- Deferred charges and accrued income +€6,186
new in 2025: €6,186
- Receivables within one year -€1,786
down €1,786 (-89.3%), from €2,000 to €214
of which Other amounts receivable: -€2,000
- Reserves +€20,281
new in 2025: €20,281
- Tax, wage and social debts +€11,344
new in 2025: €11,344
- Trade debts +€7,754
new in 2025: €7,754
- Other debts +€5,981
up €5,981 (+391%), from €1,529 to €7,510
- Profit (loss) carried forward +€1,529
up €1,529, from -€1,529 to €0
- Gross operating margin +€29,662
up €29,662, from -€1,529 to €28,133
- Taxes +€6,218
new in 2025: €6,218
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,000 | €48,889 | +€46,889 | +2,344% |
| Current assets | 29/58 | €2,000 | €48,889 | +€46,889 | +2,344% |
| Amounts receivable within one year | 40/41 | €2,000 | €214 | -€1,786 | -89.3% |
| Trade receivables | 40 | - | €214 | +€214 | |
| Other amounts receivable | 41 | €2,000 | €0 | -€2,000 | -100% |
| Cash at bank and in hand | 54/58 | - | €42,488 | +€42,488 | |
| Deferred charges and accrued income | 490/1 | - | €6,186 | +€6,186 | |
| Total equity and liabilities | 10/49 | €2,000 | €48,889 | +€46,889 | +2,344% |
| Equity | 10/15 | €471 | €22,281 | +€21,810 | +4,631% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | - | €20,281 | +€20,281 | |
| Distributable reserves | 133 | - | €20,281 | +€20,281 | |
| Profit (loss) carried forward | 14 | -€1,529 | €0 | +€1,529 | |
| Amounts payable | 17/49 | €1,529 | €26,608 | +€25,079 | +1,640% |
| Amounts payable within one year | 42/48 | €1,529 | €26,608 | +€25,079 | +1,640% |
| Trade debts | 44 | - | €7,754 | +€7,754 | |
| Suppliers | 440/4 | - | €7,754 | +€7,754 | |
| Taxes, remuneration and social security | 45 | - | €11,344 | +€11,344 | |
| Taxes | 450/3 | - | €11,344 | +€11,344 | |
| Other amounts payable | 47/48 | €1,529 | €7,510 | +€5,981 | +391% |
| Gross operating margin | 9900 | -€1,529 | €28,133 | +€29,662 | |
| Operating profit (loss) | 9901 | -€1,529 | €28,133 | +€29,662 | |
| Financial charges | 65/66B | - | €105 | +€105 | |
| Recurring financial charges | 65 | - | €105 | +€105 | |
| Profit (loss) for the period before taxes | 9903 | -€1,529 | €28,027 | +€29,556 | |
| Income taxes | 67/77 | - | €6,218 | +€6,218 | |
| Profit (loss) for the period | 9904 | -€1,529 | €21,810 | +€23,339 | |
| Profit (loss) for the period to be appropriated | 9905 | -€1,529 | €21,810 | +€23,339 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.